Obermann EC - Search Results

1

Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis.

Obermann EC, Went P, Zimpfer A, Tzankov A, Wild PJ, Stoehr R, Pileri SA, Dirnhofer S. Obermann EC, et al. BMC Cancer. 2005 Dec 20;5:162. doi: 10.1186/1471-2407-5-162. BMC Cancer. 2005. PMID: 16368013 Free PMC article.

2

Cyclin B1 expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.

Obermann EC, Went P, Pehrs AC, Tzankov A, Wild PJ, Pileri S, Hofstaedter F, Dirnhofer S. Obermann EC, et al. Oncol Rep. 2005 Dec;14(6):1461-7. Oncol Rep. 2005. PMID: 16273239

3

Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome.

Tzankov A, Gschwendtner A, Augustin F, Fiegl M, Obermann EC, Dirnhofer S, Went P. Tzankov A, et al. Among authors: obermann ec. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2125-32. doi: 10.1158/1078-0432.CCR-05-2135. Clin Cancer Res. 2006. PMID: 16609025

4

Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phase.

Obermann EC, Went P, Tzankov A, Pileri SA, Hofstaedter F, Marienhagen J, Stoehr R, Dirnhofer S. Obermann EC, et al. J Clin Pathol. 2007 Jul;60(7):794-7. doi: 10.1136/jcp.2006.040956. Epub 2006 Sep 1. J Clin Pathol. 2007. PMID: 16950856 Free PMC article.

5

Aberrations of the MYC gene in unselected cases of diffuse large B-cell lymphoma are rare and unpredictable by morphological or immunohistochemical assessment.

Obermann EC, Csato M, Dirnhofer S, Tzankov A. Obermann EC, et al. J Clin Pathol. 2009 Aug;62(8):754-6. doi: 10.1136/jcp.2009.065227. J Clin Pathol. 2009. PMID: 19638549

6

BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma.

Obermann EC, Csato M, Dirnhofer S, Tzankov A. Obermann EC, et al. J Clin Pathol. 2009 Oct;62(10):903-7. doi: 10.1136/jcp.2009.066597. J Clin Pathol. 2009. PMID: 19783718

7

Tissue microarray construction from bone marrow biopsies.

Obermann EC, Marienhagen J, Stoehr R, Wuensch PH, Hofstaedter F. Obermann EC, et al. Biotechniques. 2005 Dec;39(6):822, 824, 826. doi: 10.2144/000112073. Biotechniques. 2005. PMID: 16382898 Free article. No abstract available.

8

Pax-5 protein expression in bladder cancer: a preliminary study that shows no correlation to grade, stage or clinical outcome.

Denzinger S, Burger M, Hammerschmied CG, Wieland WF, Hartmann A, Obermann EC, Stoehr R. Denzinger S, et al. Among authors: obermann ec. Pathology. 2008 Aug;40(5):465-9. doi: 10.1080/00313020802197871. Pathology. 2008. PMID: 18604731

9

BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin's lymphoma from primary mediastinal large B-cell lymphoma.

Hoeller S, Zihler D, Zlobec I, Obermann EC, Pileri SA, Dirnhofer S, Tzankov A. Hoeller S, et al. Among authors: obermann ec. Histopathology. 2010 Jan;56(2):217-28. doi: 10.1111/j.1365-2559.2009.03462.x. Histopathology. 2010. PMID: 20102401

10

Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade.

Burger M, Denzinger S, Hartmann A, Wieland WF, Stoehr R, Obermann EC. Burger M, et al. Among authors: obermann ec. Br J Cancer. 2007 Jun 4;96(11):1711-5. doi: 10.1038/sj.bjc.6603784. Epub 2007 May 15. Br J Cancer. 2007. PMID: 17505513 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters